NMDAr autoimmune encephalitis

NMDAr autoimmune encephalitis

Excellentrank

This is the first-ever Clinical Trial for a promising new drug, Inebilizumab, to treat anti-NMDA receptor encephalitis, and will be funded by the National Institutes of Health (NIH). For more information on autoimmune en…

Related tracks

See all